Target: Stephen Ostroff, M.D., Acting FDA Commissioner
Goal: Investigate claims of severe skin reactions with use of EOS lip balm and pursue corrective actions.
A class-action lawsuit has been filed claiming that many users of EOS lip balm experience severe skin reactions including rashes, blistering, bleeding, and loss of pigmentation. These symptoms, the claimants indicate, last anywhere from a few days to several months.
EOS, makers of a popular lip balm that comes in a spherical container in a wide variety of flavors, is aware of the complaints, but has made no move to put warning labels on their packaging or advertising. The suit, in addition to seeking damages, asks EOS to implement those awareness measures. EOS states that the suit is without merit and claims that their products meet or exceed all safety measures set for the industry.
Demand the FDA conduct an independent review of EOS’ products and processes, investigate the claims mentioned in the class-action lawsuit, and take appropriate steps based upon the results of the investigation.
Dear Dr. Ostroff,
American consumers use lip balm for a variety of reasons including UV protection and to ease chapped, dry lips. A popular lip balm, EOS, may be causing severe skin irritations to some if its users. A class-action lawsuit claims users experience symptoms ranging from rashes to blistering, bleeding, and even loss of pigmentation. Although symptoms are temporary, lasting from a few days to several months, lip balm users are trying to prevent such issues, not suffer from them.
EOS indicates that their products meet or exceed all current safety standards for the industry and are completely safe to use. They have refused to place any warning labels in their advertising or on their product packaging.
We demand that EOS’ products and processes are reviewed by independent parties and that necessary steps are taken to prevent such adverse reactions in the future.
[Your Name Here]
Photo Credit: Peggy_Marco